Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 19, 2025
European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?Jérôme de Seze, Chiara Zecca, Giovanni Castelnovo, et al.
Journal of Psychosomatic Research|February 25, 2021
Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?Stephanie Rodgers, Pasquale Calabrese, Vladeta Ajdacic-Gross, et al.
Multiple Sclerosis and Related Disorders|August 7, 2022
Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis RegistryMina Stanikić, Anke Salmen, Andrew Chan, et al.
Multiple Sclerosis and Related Disorders|May 7, 2020
Development and validation of the self-reported disability status scale (SRDSS) to estimate EDSS-categoriesMarco Kaufmann, Anke Salmen, Laura Barin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational studyChiara Zecca, Arianna Merlini, Giulio Disanto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 29, 2019
How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosisLaura Barin, Christian P Kamm, Anke Salmen, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2023
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosisFrancesco Marchi, Chiara Kessler, Daniela Distefano, et al.
Neurology|January 14, 2021
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple SclerosisMaria A Rocca, Paola Valsasina, Alessandro Meani, et al.
JMIR Medical Informatics|October 17, 2022
The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language ProcessingDeborah Chiavi, Christina Haag, Andrew Chan, et al.
BMJ Neurology Open|April 8, 2026
Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosisMina Stanikić, Nina Steinemann, Jesús López-Alcalde, et al.
Pageof 17